Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07807579
PHASE4

Neuroprotective Impact of Dexmedetomidine Versus Propofol on Intracranial Pressure Monitoring in Adult Traumatic Brain Injury Patients

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

To investigate whether dexmedetomidine or propofol is more effective in controlling intracranial pressure (ICP) (assessed via optic nerve sheath diameter "ONSD" as a primary outcome) and which is more effective in suppressing lipid peroxidation (measured via malondialdehyde "MDA" as a secondary outcome). This double-blind randomized controlled trial aims to bridge this research gap by evaluating the biochemical neuroprotective efficacy alongside the clinical outcomes of both agents in TBI patients.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-10-01

Completion Date

2028-01-01

Last Updated

2026-09-08

Healthy Volunteers

No

Interventions

DRUG

Propofol

evaluate intracranial pressure and serum Malondialdehyde (MDA) levels

DRUG

Dexmedetomidine

evaluate intracranial pressure and serum Malondialdehyde (MDA) levels